Pharmingen
Records under this name other than patents Pharmingen holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 1 of 1 · Back to Pharmingen
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 5,858,682 | E2A/pbx1 fusion protein specific monoclonal antibodies Term ended Term ended no later than Jan 12, 2019 · Low confidence | Term ended | Term ended no later than Jan 12, 2019 | Low confidence |